| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54d0b5014ffb6e8d9bb5aa17ab0a0990 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c482b6e3aadc404fe89d5eb3893b248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f0770b50b5395db032e5a85c3e7541 |
| publicationDate |
2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015082545-A1 |
| titleOfInvention |
Method for the selective determination of placental growth factor 2 |
| abstract |
The present invention relates to an immunoassay method for placental growth factor 2 (PlGF- 2) detection in pregnant subjects. Furthermore the invention relates to the use of said method for the diagnosis, prognosis, risk assessment and therapy control of prenatal disorders comprising the determination of the level of PlGF-2 in said pregnant subjects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3682250-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11327071-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022038064-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017197573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021009260-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109196362-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11112403-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11333672-B2 |
| priorityDate |
2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |